Specific diseases
Ultrasonography in gout: utility in diagnosis and monitoring
S.N. Christiansen1, M. Østergaard2, L. Terslev3
- Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Copenhagen, Denmark. sara.nysom.christiansen@regionh.dk
- Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Copenhagen, and Department of Clinical Medicine, University of Copenhagen, Denmark.
- Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Copenhagen, Denmark.
CER11670
2018 Vol.36, N°5 ,Suppl.114
PI 0061, PF 0067
Specific diseases
Free to view
(click on article PDF icon to read the article)
PMID: 30296983 [PubMed]
Received: 29/08/2018
Accepted : 30/08/2018
In Press: 01/10/2018
Published: 01/10/2018
Abstract
The use of ultrasonography has a considerable potential for diagnosis and monitoring of gout due to its capacity to detect urate crystal deposits in joints, e.g. on the cartilage surface, visualised as the double contour sign, and in soft tissues, e.g. as tophi. Furthermore, ultrasonography can visualise both synovitis and bone erosion. Consensus-based definitions for ultrasonographic elementary lesions in gout were validated in 2015, and ultrasonography is already included in the 2015 ACR/EULAR classification criteria for gout. This report evaluates the current literature on the use of ultrasonography for diagnosing and monitoring gout.